Tema ETFs launches ICOM and THRU, its first commodity ETFs, giving investors new ways to diversify and hedge against ...

NEW YORK – Tema ETFs ("Tema") announced that its LAZR ETF has increased its Anthropic allocation to 10.5%, coinciding with yesterday's highly anticipated S-1 filing. LAZR has the highest exposure to ...

Years of underinvestment and lengthy development timelines constrain new supply, supporting the case for a potential commodity supercycle. Energy and materials account for less than 6% of the S&P 500, ...

Prediction market pioneer Kalshi’s estimated ARR reached $4 billion as of August 2026, amid a funding round valuing the company at roughly $40 billion. 1 Bernstein forecasts annual prediction market ...

Anthropic is already profitable, with a 19% margin in Q2 and $3.9 billion of operating cash flow in H1 2026. 1 Enterprise adoption is deepening, while revenue generated per dollar of compute has ...

Energy Transfer (ET) is a U.S. energy infrastructure company operating one of the largest pipeline networks in the country. Its systems move natural gas, crude oil and natural gas liquids from major ...

AI and reindustrialization are accelerating power demand, igniting $7 trillion in upgrade and new investment across the electrification value chain. Investing in companies that are positioned to ...

Shell (SHEL-LN) is a global integrated energy company with one of the world’s largest LNG portfolios. Shell produces oil and gas, including from deepwater fields, and operates trading, refining, and ...

Consult with your financial advisor to explore how Tema ETF solutions may support your investing objectives. ETFs, or exchange traded funds, share characteristics of both stocks and traditional mutual ...

NEW YORK, Sep 9, 2026 – Tema ETFs (“Tema”), a leader in actively managed exchange-traded funds, today announced the launch of the Tema Trading & Prediction Markets ETF (DICE). DICE invests in a new ...

Healthcare sits near a historic low in market ownership, even as the sector's growth profile strengthens, with 2027 earnings growth expected to trail only tech. Earnings growth, drug innovation, ...